These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20805136)

  • 1. Analysis of GNAQ mutations, proliferation and MAPK pathway activation in uveal melanomas.
    Pópulo H; Vinagre J; Lopes JM; Soares P
    Br J Ophthalmol; 2011 May; 95(5):715-9. PubMed ID: 20805136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the MAPK pathway is a common event in uveal melanomas although it rarely occurs through mutation of BRAF or RAS.
    Zuidervaart W; van Nieuwpoort F; Stark M; Dijkman R; Packer L; Borgstein AM; Pavey S; van der Velden P; Out C; Jager MJ; Hayward NK; Gruis NA
    Br J Cancer; 2005 Jun; 92(11):2032-8. PubMed ID: 15928660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational analysis of selected genes in the TGFbeta, Wnt, pRb, and p53 pathways in primary uveal melanoma.
    Edmunds SC; Kelsell DP; Hungerford JL; Cree IA
    Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):2845-51. PubMed ID: 12202501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of p53-induced apoptosis effector PERP in primary uveal melanomas: downregulation is associated with aggressive type.
    Paraoan L; Gray D; Hiscott P; Ebrahimi B; Damato B; Grierson I
    Exp Eye Res; 2006 Oct; 83(4):911-9. PubMed ID: 16784742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of BRAF mutations in uveal melanoma.
    Rimoldi D; Salvi S; Liénard D; Lejeune FJ; Speiser D; Zografos L; Cerottini JC
    Cancer Res; 2003 Sep; 63(18):5712-5. PubMed ID: 14522889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What hope for the future? GNAQ and uveal melanoma.
    Sisley K; Doherty R; Cross NA
    Br J Ophthalmol; 2011 May; 95(5):620-3. PubMed ID: 21378004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of PI3K/Akt signaling pathway in hepatocyte growth factor-induced migration of uveal melanoma cells.
    Ye M; Hu D; Tu L; Zhou X; Lu F; Wen B; Wu W; Lin Y; Zhou Z; Qu J
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):497-504. PubMed ID: 18234991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional analysis of the p53 pathway in response to ionizing radiation in uveal melanoma.
    Sun Y; Tran BN; Worley LA; Delston RB; Harbour JW
    Invest Ophthalmol Vis Sci; 2005 May; 46(5):1561-4. PubMed ID: 15851551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cripto-1 expression in uveal melanoma: an immunohistochemical study.
    Mallikarjuna K; Vaijayanthi P; Krishnakumar S
    Exp Eye Res; 2007 Jun; 84(6):1060-6. PubMed ID: 17412323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and immunohistochemical analyses of uveal melanoma patient cohort.
    Sarubi HC; Pereira NB; Gomes CC; Gomez RS; Carmo ACM; Melo FM; Bastos-Rodrigues L; Pedrosa MS; Friedman E; De Marco L
    Melanoma Res; 2019 Jun; 29(3):248-253. PubMed ID: 30480620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The PI3K/Akt and mTOR/P70S6K signaling pathways in human uveal melanoma cells: interaction with B-Raf/ERK.
    Babchia N; Calipel A; Mouriaux F; Faussat AM; Mascarelli F
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):421-9. PubMed ID: 19661225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The in vivo modulatory effects of an anterior-chamber microenvironment on uveal melanoma.
    Mudhar HS; Saunders E; Rundle P; Rennie IG; Sisley K
    Br J Ophthalmol; 2009 Apr; 93(4):535-40. PubMed ID: 19019926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and distribution of MMPs and TIMPs in human uveal melanoma.
    Lai K; Conway RM; Crouch R; Jager MJ; Madigan MC
    Exp Eye Res; 2008 Jun; 86(6):936-41. PubMed ID: 18423620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of the KIT/SCF in uveal melanoma does not translate into clinical efficacy of imatinib mesylate.
    Hofmann UB; Kauczok-Vetter CS; Houben R; Becker JC
    Clin Cancer Res; 2009 Jan; 15(1):324-9. PubMed ID: 19118061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased p21-activated kinase-1 expression is associated with invasive potential in uveal melanoma.
    Pavey S; Zuidervaart W; van Nieuwpoort F; Packer L; Jager M; Gruis N; Hayward N
    Melanoma Res; 2006 Aug; 16(4):285-96. PubMed ID: 16845324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutant GNAQ promotes cell viability and migration of uveal melanoma cells through the activation of Notch signaling.
    Liu H; Lei C; Long K; Yang X; Zhu Z; Zhang L; Liu J
    Oncol Rep; 2015 Jul; 34(1):295-301. PubMed ID: 25955651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of bcl-2 in uveal malignant melanoma.
    Jay V; Yi Q; Hunter WS; Zielenska M
    Arch Pathol Lab Med; 1996 May; 120(5):497-8. PubMed ID: 8639055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenic G Protein GNAQ Induces Uveal Melanoma and Intravasation in Mice.
    Huang JL; Urtatiz O; Van Raamsdonk CD
    Cancer Res; 2015 Aug; 75(16):3384-97. PubMed ID: 26113083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Mutation Rates of GNAQ or GNA11 in Cases of Uveal Melanoma in Japan.
    Ominato J; Fukuchi T; Sato A; Yamaguchi N; Kobayashi K; Cho H; Oyama T; Ajioka Y
    Appl Immunohistochem Mol Morphol; 2018 Oct; 26(9):658-663. PubMed ID: 28248732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitogen-activated protein kinase signaling is activated in prostate tumors but not mediated by B-RAF mutations.
    Burger M; Denzinger S; Hammerschmied C; Tannapfel A; Maderstorfer A; Wieland WF; Hartmann A; Stoehr R
    Eur Urol; 2006 Nov; 50(5):1102-9; discussion 1109-10. PubMed ID: 16413100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.